AIDA PHARMACEUTICALS, INC. ACQUIRES 77.5% OF CHINESE GENE DRUG PIONEER SHANGHAI QIAER BIO-TECHNOLOGY

Aida Pharmaceuticals, Inc., one of mainland China's leading pharmaceutical companies, announced that the Company has completed its acquisition of the majority control of Shanghai Qiaer Bio-Technology Co., Ltd. BioSpace (http://www.biospace.com/news_story.aspx?StoryId=27273)